Abstract The 2008 Physical Activity (PA) Guidelines recommend engaging in at least 2.5 h (10 MET-hours/ week) of moderate intensity PA per week (defined as 4 METs) to reduce risk of morbidity and mortality. This analysis was conducted to investigate whether this recommendation can be extended to breast cancer survivors. Data from four studies of breast cancer survivors measuring recreational PA from semi-quantitative questionnaires a median of 23 months post-diagnosis (interquartile range 18-32 months) were pooled in the After Breast Cancer Pooling Project (n = 13,302). Delayed entry Cox proportional hazards models were applied in data analysis with adjustment for age, post-diagnosis body mass index, race/ ethnicity, menopausal status, TNM stage, cancer treatment, and smoking history. Engaging in at least 10 MET-hours/ week of PA was associated with a 27% reduction in allcause mortality (n = 1,468 events, Hazard Ratio (HR) = 0.73, 95% CI, 0.66-0.82) and a 25% reduction in breast cancer mortality (n = 971 events, HR = 0.75, 95% CI 0.65-0.85) compared with women who did not meet the PA Guidelines (\10 MET-hours/week). Risk of breast cancer recurrence (n = 1,421 events) was not associated with meeting the PA Guidelines (HR = 0.96, 95% CI, 0.86-1.06). These data suggest that adhering to the PA guidelines may be an important intervention target for reducing mortality among breast cancer survivors.
Introduction
Physical activity (PA), one of the major determinants of energy balance, is inversely associated with all-cause mortality [1] . The 2008 PA Guidelines from the United States Department of Health and Human Services recommend 2.5 h per week of moderate to vigorous intensity activity to lower risk of all-cause mortality, coronary heart disease, stroke, hypertension, and type 2 diabetes, including older adults [1] . Intensity of PA is often expressed as metabolic equivalents (METs), and analytic guidelines for international PA questionnaires recommend defining moderate activity as 4 METs and vigorous activity as 8 METs [2, 3] .
These values are consistent with the PA guidelines that define 3-5.9 METs as moderate and C6 METS as vigorous PA [1] .
Among breast cancer survivors, the data are less definitive. A recent review reported that higher PA was associated with improved survival in four studies, whereas no association was found in three studies, leading to an equivocal conclusion [4] . Meta-analyses combining estimates across published studies have been complicated by study design issues, including differences in eligibility criteria, timing of exposure measurement, method of PA assessment, and adjustment of covariates. Pooling individual-level data provides the ability to apply similar analytic criteria across cohorts.
Therefore, we evaluated the association of PA with allcause mortality, breast cancer-specific mortality, and breast cancer recurrence using data from more than 13,000 breast cancer survivors in the after Breast Cancer Pooling Project (ABCPP). The ABCPP pooled data from four epidemiological studies recruited from multiple US sites and Shanghai, China [5] . PA was measured 18-48 months post-diagnosis. We compared outcomes for women in the pooled cohort who did versus those who did not meet the 2008 PA Guidelines [1] . We adjusted for similar covariates across studies and tested for effect modification by key characteristics (body mass index (BMI), menopausal status, and hormone receptor [ER/PR] status).
Methods

Study population
Detailed information about each of the four prospective cohorts of breast cancer survivors [6] [7] [8] [9] as well as the overall ABCPP is described elsewhere [5] 
Outcome ascertainment
Outcomes of interest included all-cause mortality, breast cancer-specific mortality, and breast cancer recurrence, defined as a local/regional recurrence, distant recurrence/ metastasis, or development of a new breast primary.
PA ascertainment
This analysis included recreational PA only (Table 1) . PA was assessed in the LACE study with a questionnaire adapted from the Arizona Activity Frequency Questionnaire assessing recreational activity, which has been validated against doubly labeled water [10] . Therefore, LACE data were restricted to information related to recreational activities. Recreational PA was assessed in the NHS by querying level of participation in a range of commonly reported recreational activities [11] . This questionnaire was validated against PA diaries and was found to accurately rank participants for recreational PA [12] . In the SBCSS, PA information was collected using a validated PA questionnaire during in-person interviews [13] . Study participants were asked if they participated in recreational exercise regularly (at least twice a week) or not since diagnosis. Information on frequency and duration was obtained for all exercise activities. For the WHEL study, the Women's Health Initiative (WHI) PA Questionnaire, which has been validated using accelerometry [14] , assessed frequency, duration, and speed of walking outside the home and frequency and duration of participation in each of three intensity levels of exercise (mild, moderate, or strenuous). This analysis focused on summary PA data between 18 and 48 months post-diagnosis that combined information on intensity in terms of metabolic equivalents (METs) [15] with frequency and duration. Meeting PA guidelines was defined as engaging in C10 MET-hours/week, equivalent to 2.5 h of moderate PA per week (4 METs) or to 1.25 h of vigorous PA (8 METs) per week [3] . PA was also categorized into quintiles based on the pooled data set.
Covariates
Comparable data pooled across cohorts that may be related to both PA levels and survival after breast cancer include age at diagnosis in years, TNM stage (I, II, or III), joint ER/ PR status (ER?/PR?, ER?/PR-, ER-/PR?, or ER-/ PR-), race/ethnicity (non-Hispanic White, non-Hispanic Black, Asian, Hispanic, or Other), menopausal status (premenopausal or postmenopausal), smoking (never, past, or current), and BMI (kg/m 2 ). To evaluate effect modification, BMI was categorized using the classifications of underweight (\18.5 kg/m 2 ), normal weight (18.5-24.9 kg/ m 2 ), overweight (25-29.9 kg/m 2 ), and obese (C30 kg/m 2 ).
Analysis
We excluded women with stage IV cancer at diagnosis, missing date of first survey/enrollment or lacking follow-up time, or missing PA exposure, resulting in 13,302 women in the final analytic sample. Levels of PA were summarized overall and by cohort. Frequency distributions were calculated for categorical variables and means with standard deviations (SD) for continuous variables according to whether women met the PA guidelines ([10 MET-hours/ week) [1] . Follow-up ended at date of death or date of recurrence, depending on the outcome, or date of last contact (i.e., date of last follow-up survey or date of last registry linkage, whichever was most recent).
The multivariate-adjusted analysis involved two initial stages, followed by an aggregated (pooled individual data) analysis. First, we conducted individual study analyses using delayed entry Cox proportional hazards models to estimate hazard ratios (HR) and 95% confidence intervals (CI), with time since diagnosis as the time scale. The entry date was the date of the baseline survey for LACE and WHEL, second follow-up survey at 18 months for SBCSS, or the date of the first survey after diagnosis for the NHS. Second, we conducted meta-analyses with the studyspecific hazards ratios using inverse-variance weights in random-effects models [16] . The Q test statistic was used to test for heterogeneity in risk estimates across studies [17] . Because of no evidence of heterogeneity (P [ 0.05), individual data from the four cohorts were combined, and a pooled analysis was conducted for the exposure-disease associations of interest using delayed entry Cox proportional hazards models stratified by study.
Covariates included age, post-diagnosis BMI, race/ethnicity, menopausal status, TNM stage, cancer treatment, and smoking. We evaluated possible effect modification in the associations between PA, recurrence, and survival by BMI category, menopausal status, and ER/PR status. Statistical significance of interaction terms was estimated by the Wald test, including a cross-product term of the exposure and the potential effect modifier in the delayed entry Cox models.
Sensitivity analyses were conducted, including (1) cases diagnosed after 1990 only, (2) women having a PA assessment within 2 years of diagnosis, (3) women who survived beyond 2 years of the post-diagnosis physical activity assessment, and (4) study participants with missing data. For this latter analysis, we included a missing data indicator category for each covariate. Recurrence analyses were repeated restricting the outcome to distant (vs. local) recurrences.
Each contributing study received institutional review board approval, and informed consent was obtained for all study participants.
Results
Median PA was 10.0 MET-hours/week (interquartile range 2.3-21.3), the equivalent of engaging in 2.5 h of moderate intensity PA per week (Table 2) . Approximately half (range 48.3% in NHS to 53.2% in WHEL) of the women in each cohort met the PA guidelines. Women who met the PA guidelines (10 MET-hours/week) were younger, had earlier stage disease, were less likely to smoke, and were more likely to be in the ''normal'' weight category (BMI 18.5-24.9 kg/m 2 ) ( Table 3 , P \ 0.05 for all comparisons). Engaging in at least 10 MET-hours/week of PA was associated with a 27% (HR = 0.73, 95% CI, 0.66-0.82) reduction in all-cause mortality (n = 1,468 events) compared with women who did not meet PA guidelines (\10 MET-hours/week) ( Table 4 ). Higher levels of PA were associated with lower risk of death from any cause. A greater risk reduction was conferred with each increasing quintile of PA (10%, 23%, 29%, and 40% relative to the lowest quintile, Table 4 ). For breast cancer mortality, significant protective associations were observed for quintiles four (median 18.7 MET-hours/week) and five (median 36.5 MET-hours/week), but not at lower levels of activity. Being physically active was not associated with breast cancer recurrence, and no association remained after further restricting the analysis to women who had a distant recurrence. All associations with recurrence were null across the spectrum of PA levels, i.e. meeting the PA guidelines or engaging in the highest category of PA.
There was no evidence for effect modification by BMI category, menopausal status, or ER/PR status in the associations between physical activity and all outcomes (allcause mortality, breast cancer mortality, and breast cancer recurrence; Table 5 ), as defined by P for interaction\0.05. Each of the sensitivity analyses was consistent with the primary analyses.
Discussion
In this large pooling project of breast cancer survivors, we observed a reduction in death from any cause and death from breast cancer for women who met the PA guidelines of 10 MET-hours/week 18-48 months post-diagnosis. We also found that engagement of PA at levels higher than those recommended conferred even further benefit.
These data are consistent with a growing body of evidence suggesting that participation in PA after breast cancer diagnosis is a modifiable behavior that can improve prognosis. Two recent meta-analyses reported that PA assessed at varying time points (pre-diagnosis, at diagnosis, post-diagnosis) was associated with 29% and 41% lower mortality, summarized from 15,886 (n = 9 studies) and 12,108 (n = 6 studies) breast cancer survivors, respectively [18, 19] . The smaller meta-analyses excluded one study because of not having a summary variable of total PA [20] , a second study (WHEL) because it was a dietary intervention [21] , and provided no rationale for excluding the third study [22] . The WHI also reported that PA of 9 or more MET-hours/week after breast cancer diagnosis was associated with lower overall mortality (HR = 0.54, 95% CI 0.38-0.79) among 4,643 post-menopausal women [23] .
Prior studies have also consistently demonstrated inverse associations between PA and mortality from breast cancer. The meta-analysis of six studies restricted to those reporting on mortality from breast cancer reported that post-diagnosis PA reduced breast cancer death by 34% (HR = 0.66, 95% CI 0.57-0.77) [19] , whereas the more inclusive meta-analysis of nine studies did not differentiate all-cause from breast cancer-specific mortality [18] . Similarly, WHI reported PA of 9 or more MET-hours/week after diagnosis was associated with lower breast cancer mortality (HR = 0.61, 95% CI, 0.35-0.99) [23] .
Data are equivocal regarding the association between PA and breast cancer recurrence. There was no association between PA and breast cancer recurrence (HR = 0.96, 95% CI, 0.86-1.06) in our pooled analysis of LACE, NHS, WHEL, and SBCSS. The meta-analysis, including the LACE, NHS, and WHEL studies, reported no association between PA and breast cancer recurrence [18] , whereas the other meta-analysis that only included LACE and NHS [19] did report a reduced risk of recurrence with higher PA (HR = 0.76, 95% CI, 0.66-0.87) [19] . Measurement error in the recurrence outcome likely explains the lack of a consistent signal.
The previous literature suggests that the mechanisms by which PA lowers risk of mortality in the general population might apply to breast cancer survivors [24] . Those mechanisms, summarized in the national PA guidelines [1] , include improved physical fitness (aerobic capacity, strength, and flexibility) and enhanced physical and cognitive function. Changes that result from PA reflect greater physiological capability and reserve for responding to the stresses of disease and aging and result in better cardiorespiratory, metabolic, hormonal, neurological, muscular, IQR inter-quartile range and cognitive outcomes and translate to lower overall risk of mortality [25] . Our observed protective association was evident in normal and overweight women, but no significant benefit of PA on survival among obese women was found. This finding is similar to those reported by other studies that differentiated BMI categories between overweight (25-29.9 kg/m 2 ) and obese (C30 kg/m 2 ) [23, 26] . In contrast, studies that combined overweight and obese into one category reported no differences in effect by BMI category, i.e., associations were similar to the normal weight category [11, 27] . Possible explanations for this result include that we may not have had sufficient power to detect inverse associations in the obese subgroup, or differential misclassification in the exposure assessment by obesity status.
Strengths of this analysis include post-diagnosis PA assessment assessed at a similar time point across studies and adjustment for similar covariates in four prospective studies of breast cancer survivors. This adjustment minimized heterogeneity between studies that complicates interpretation of meta-analyses. Another major strength was improved power to detect differences in the association between PA and health outcomes by key characteristics, such as menopausal status, hormone receptor status, and BMI.
When considering these findings, limitations should be noted. We did not evaluate change in PA over time as these data were not available for all cohorts. Recent data from WHEL suggest that the usual pattern of PA is more predictive of better health outcomes than the trajectory of PA [28] . Underlying health status influences both the propensity to exercise and to die, but the inverse association between PA and mortality in our study was still observed in analyses restricted to women who survived at least 2 years beyond the PA assessment. Data on PA were missing for more than 10% of the cohort, but analyses including missing values as a separate category were concordant with the complete case analyses. It is highly probable that levels of PA were over reported, as half of women met PA guidelines. However, we were able to detect a dose-response in the association between amount of PA and survival, suggesting that the ranking of PA levels was conserved.
In conclusion, we observed a 27% reduction in risk of death from any cause among women who adhered to the PA guidelines 18-48 months post-diagnosis, but there was no evidence that this reduction was associated with decreased risk of breast cancer recurrence. Studies are still needed to help disentangle the mechanisms by which PA may improve survival among breast cancer survivors. Nonetheless, PA appears to confer important physiological benefits to breast cancer survivors, which may ultimately improve and extend overall survival after a diagnosis of breast cancer [25] . Therefore, methods to promote PA among women after a breast cancer diagnosis should be pursued. Bold values indicate statistically significant (P \ 0.05) p-values and confidence intervals excluding 1 a Delayed entry Cox models stratified by study and adjusted for age at diagnosis, race, menopausal status, TNM stage, hormone receptor status, treatment (chemotherapy/radiation/both), post-diagnosis body mass index, and smoking status b Participants were not included in cause-specific death models if cause of death was unspecified (n = 33) Table 5 Risk a of breast cancer recurrence, breast cancer mortality, and all-cause mortality by meeting (vs. not meeting) physical activity guidelines by BMI category, menopausal status, and hormone receptor status, after breast cancer pooling project a Delayed entry Cox models stratified by study and adjusted for age at diagnosis, race, menopausal status, TNM stage, hormone receptor status, treatment (chemo/radiation/both), post-diagnosis BMI, and smoking status b P for interaction evaluated by the Wald test, estimated by including a cross-product of the exposure and the stratification variable in delayed entry Cox models
